Listing 1 - 10 of 12 | << page >> |
Sort by
|
Choose an application
Dysphagia: Clinical Management in Adults and Children, 3rd Edition provides the information you need to diagnose and manage dysphagia in patients of all ages. Emphasizing evidence-based practice, this complete resource covers topics from esophageal disorders to respiratory and iatrogenic disorders. This edition adds a new Aging and Dysphagia chapter and is updated with the latest research and advances in dysphagia management. Written by speech-language pathology educators Michael E. Groher and Michael A. Crary, this guide helps you develop clinical reasoning skills and learn today's best practices in dysphagia management.
Deglutition disorders --- Treatment. --- dysfagie --- logopedie --- Deglutition Disorders --- therapy --- Dysphagia --- Dysphagy --- Esophagus --- Ingestion disorders --- Diseases
Choose an application
Gastritis. --- Gastroesophageal reflux. --- Acid reflux disease --- Esophageal reflux --- Esophagitis, Reflux --- Gastric regurgitation --- Gastro-esophageal reflux --- Reflux disease, Acid --- Reflux esophagitis --- Regurgitation, Gastric --- Esophagus --- Heartburn --- Stomach --- Gastroenteritis --- Diseases --- Inflammation
Choose an application
This book presents a new, multi- and interdisciplinary approach to gastroesophageal reflux disease (GERD) and Barrett’s esophagus that reflects the latest advances in understanding of the disease. The role of each of the available diagnostic techniques, including endoscopy, histopathology, esophageal manometry, reflux monitoring, and EndoFLIP assessment, is carefully explained. The use of endoscopy for the purposes of mucosal ablation (radiofrequency ablation, cryoablation) and mucosal resection is described, and all aspects of anti-reflux surgery are covered, with detailed explanation of indications and techniques for standard fundoplication, endoscopic fundoplication, and surgical procedures using the LINX system and the EndoStim device. To assist the reader further, a novel interdisciplinary algorithm is presented for GERD diagnosis and treatment. In addition, the latest diagnostic and therapeutic approaches (including endoscopic and surgical resection and chemoradiation) are also presented for esophageal cancer and cancer palliation. A key feature of the book is its recognition of the contribution of different specialties in the management of GERD, and it will accordingly appeal to a wide range of practitioners.
Gastroenterology . --- Gastroenterology. --- Internal medicine --- Digestive organs --- Diseases --- Gastroesophageal reflux --- Diagnosis. --- Acid reflux disease --- Esophageal reflux --- Esophagitis, Reflux --- Gastric regurgitation --- Gastro-esophageal reflux --- Reflux disease, Acid --- Reflux esophagitis --- Regurgitation, Gastric --- Esophagus --- Heartburn
Choose an application
Esophagus --- Surgery. --- Esòfag --- Cirurgia infantil --- Cirurgia digestiva --- Cirurgia de l'aparell digestiu --- Cirurgia --- Cirurgia abdominal --- Cirurgia hepàtica --- Cirurgia intestinal --- Gastrectomia --- Cirurgia pediàtrica --- Pediatria --- Anestèsia en pediatria --- Ortopèdia pediàtrica --- Tub digestiu --- Malalties de l'esòfag --- Gola --- Esòfag.
Choose an application
Recent decades have seen remarkable advances in the treatment of upper gastrointestinal malignancies, i.e., adenocarcinoma and squamous cell carcinoma as well as gastrointestinal stromal and other rare tumors of the esophagus and stomach. While, historically, surgical resection has been the sole treatment for these tumors, multimodal therapies have meanwhile proven their efficacy. At present, pre- and postoperative chemotherapy and radiotherapy, targeted drug therapy, and stage-specific surgical approaches are all indispensable cornerstones of an individualized treatment for upper gastrointestinal malignancies. With such multimodal treatment, better outcomes comprising improved quality of life and prolonged survival have been achieved for patients. However, for many tumor entities and stages, the ideal combination and sequence of treatments is still being evaluated in clinical trials. Moreover, the value of novel approaches such as immunotherapy or robotic surgery remains a matter of research. In this Special Issue of Cancers, up-to-date original research, short communications, and comprehensive review articles on all modalities playing a role in the treatment of upper gastrointestinal malignancies have been published.
Public health & preventive medicine --- gastric cancer --- gastrectomy --- complications --- outcome --- survival --- lymph node ratio --- neoadjuvant chemotherapy --- conversion surgery --- cancer dormancy --- nuclear receptor NR2F1 --- clinical pathways --- gastric surgery --- oncological gastrectomy --- quality of care --- outcomes --- standardization --- adjuvant therapy --- gastrointestinal tract --- genetic diagnosis --- radiosensitivity --- mortality --- failure to rescue --- immunotherapy --- genetics --- esophageal cancer --- multidisciplinary --- gastric/gastroesophageal cancer --- perioperative chemotherapy --- overall survival --- relapse-free survival --- skeletal muscle index --- esophagectomy --- nutritional status --- sarcopenia --- esophageal anastomosis --- minimally invasive surgery --- induction chemotherapy --- chemo-radiotherapy --- neoadjuvant treatment --- esophageal squamous cell carcinoma --- multimodal treatment --- neoadjuvant chemoradiotherapy --- definitive chemoradiotherapy --- Lauren histotype --- gastrointestinal stromal tumor --- neuroendocrine tumor --- MALT lymphoma --- mucosal resection --- submucosal dissection --- GIST --- stomach --- neoadjuvant therapy --- imatinib --- organ preservation --- squamous cell esophageal cancer --- gastro-esophageal reflux disease --- Barrett’s esophagus --- early adenocarcinoma of esophagus --- endoscopic submucosal dissection --- endoscopic mucosal resection --- n/a --- Barrett's esophagus
Choose an application
Recent decades have seen remarkable advances in the treatment of upper gastrointestinal malignancies, i.e., adenocarcinoma and squamous cell carcinoma as well as gastrointestinal stromal and other rare tumors of the esophagus and stomach. While, historically, surgical resection has been the sole treatment for these tumors, multimodal therapies have meanwhile proven their efficacy. At present, pre- and postoperative chemotherapy and radiotherapy, targeted drug therapy, and stage-specific surgical approaches are all indispensable cornerstones of an individualized treatment for upper gastrointestinal malignancies. With such multimodal treatment, better outcomes comprising improved quality of life and prolonged survival have been achieved for patients. However, for many tumor entities and stages, the ideal combination and sequence of treatments is still being evaluated in clinical trials. Moreover, the value of novel approaches such as immunotherapy or robotic surgery remains a matter of research. In this Special Issue of Cancers, up-to-date original research, short communications, and comprehensive review articles on all modalities playing a role in the treatment of upper gastrointestinal malignancies have been published.
gastric cancer --- gastrectomy --- complications --- outcome --- survival --- lymph node ratio --- neoadjuvant chemotherapy --- conversion surgery --- cancer dormancy --- nuclear receptor NR2F1 --- clinical pathways --- gastric surgery --- oncological gastrectomy --- quality of care --- outcomes --- standardization --- adjuvant therapy --- gastrointestinal tract --- genetic diagnosis --- radiosensitivity --- mortality --- failure to rescue --- immunotherapy --- genetics --- esophageal cancer --- multidisciplinary --- gastric/gastroesophageal cancer --- perioperative chemotherapy --- overall survival --- relapse-free survival --- skeletal muscle index --- esophagectomy --- nutritional status --- sarcopenia --- esophageal anastomosis --- minimally invasive surgery --- induction chemotherapy --- chemo-radiotherapy --- neoadjuvant treatment --- esophageal squamous cell carcinoma --- multimodal treatment --- neoadjuvant chemoradiotherapy --- definitive chemoradiotherapy --- Lauren histotype --- gastrointestinal stromal tumor --- neuroendocrine tumor --- MALT lymphoma --- mucosal resection --- submucosal dissection --- GIST --- stomach --- neoadjuvant therapy --- imatinib --- organ preservation --- squamous cell esophageal cancer --- gastro-esophageal reflux disease --- Barrett’s esophagus --- early adenocarcinoma of esophagus --- endoscopic submucosal dissection --- endoscopic mucosal resection --- n/a --- Barrett's esophagus
Choose an application
Genomics technologies revolutionised biomedicine research, but the genome alone is not sufficient to capture biological complexity. Postgenomic methods, typically based on mass spectrometry, comprise the analysis of metabolites, lipids, and proteins and are an essential complement to genomics and transcriptomics. Multidimensional omics is becoming established to provide accurate and comprehensive state descriptions. This book covers the latest methodological developments for, and applications of integrative multi-omics in biomedical research.
target identification --- target validation --- label-free method for drugs --- anti-angiogenesis --- mechanism of action --- receptor tyrosine kinases --- curcumin --- natural products --- lipid --- lipidomics --- cardiac metaplasia --- Barrett’s esophagus --- esophageal adenocarcinoma --- microbiota --- DNA sensing --- IFI16 --- cGAS --- innate immunity --- protein interactions --- virus–host interactions --- post-translational modifications --- mass spectrometry --- proteomics --- transcriptomics --- multi-omics --- multi-omics analysis --- study design --- bioinformatics --- machine learning --- analysis flow --- metabolomics --- planned myocardial infarction (PMI) --- myocardial infarction (MI) --- exercise --- heart --- cheminformatics --- batch variations --- eicosanoids --- fetal calf serum --- peroxisomes --- host-pathogen interactions --- secretome --- macrophages --- acute myeloid leukemia --- HL-60 cell line --- ATRA --- induced differentiation --- transcriptome --- proteome --- transcription factors --- key molecules --- regulatory pathway modelling --- SRM --- endometriosis --- inflammation --- n/a --- Barrett's esophagus --- virus-host interactions
Choose an application
The book offers a comprehensive approach to the assessment and treatment of disturbances in facial expression, oral movement, swallowing, breathing, voice and speech production caused by developmental and acquired neurological conditions. The principles outlined are used in patients with different etiologies (e.g. stroke, tumors, traumas). F.O.T. T., developed by Kay Coombes, is a hands-on approach based on an understanding of neurological functions and the way we learn from experience. The approach aims to give the patient experience of physiological posture and movement using facial-oral functions in normal activities of daily living (ADL). Rather than mere “exercises”, F.O.T.T involves meaningful activities aiming to promote participation, according to ICF criteria. Four main areas are covered: nutrition, oral hygiene, nonverbal communication and speech. Each chapter summarises the problems of severely ill patients and shows the clinical reasoning behind the solutions offered. Separate chapters discuss tracheostomy management and the training of the carers involved, including relatives. The chapter authors are experienced specialists (physio-, occupational- and speech-language therapists and physicians), whose contributions aim to provide interdisciplinary perspectives and translate latest research into clinical practice.
Neurology . --- Rehabilitation medicine. --- Speech pathology. --- Neurology. --- Rehabilitation Medicine. --- Speech Pathology. --- Defective speech --- Disorders of speech --- Speech, Disorders of --- Speech defects --- Speech pathology --- Communicative disorders --- Medicine, Rehabilitation --- Rehabilitation medicine --- Rehabilitation --- Medicine, Physical --- Medicine --- Nervous system --- Neuropsychiatry --- Diseases --- Eating disorders --- Deglutition disorders --- Treatment. --- Dysphagia --- Dysphagy --- Esophagus --- Ingestion disorders
Choose an application
Genomics technologies revolutionised biomedicine research, but the genome alone is not sufficient to capture biological complexity. Postgenomic methods, typically based on mass spectrometry, comprise the analysis of metabolites, lipids, and proteins and are an essential complement to genomics and transcriptomics. Multidimensional omics is becoming established to provide accurate and comprehensive state descriptions. This book covers the latest methodological developments for, and applications of integrative multi-omics in biomedical research.
Research & information: general --- Biology, life sciences --- target identification --- target validation --- label-free method for drugs --- anti-angiogenesis --- mechanism of action --- receptor tyrosine kinases --- curcumin --- natural products --- lipid --- lipidomics --- cardiac metaplasia --- Barrett’s esophagus --- esophageal adenocarcinoma --- microbiota --- DNA sensing --- IFI16 --- cGAS --- innate immunity --- protein interactions --- virus–host interactions --- post-translational modifications --- mass spectrometry --- proteomics --- transcriptomics --- multi-omics --- multi-omics analysis --- study design --- bioinformatics --- machine learning --- analysis flow --- metabolomics --- planned myocardial infarction (PMI) --- myocardial infarction (MI) --- exercise --- heart --- cheminformatics --- batch variations --- eicosanoids --- fetal calf serum --- peroxisomes --- host-pathogen interactions --- secretome --- macrophages --- acute myeloid leukemia --- HL-60 cell line --- ATRA --- induced differentiation --- transcriptome --- proteome --- transcription factors --- key molecules --- regulatory pathway modelling --- SRM --- endometriosis --- inflammation --- n/a --- Barrett's esophagus --- virus-host interactions
Choose an application
Recent decades have seen remarkable advances in the treatment of upper gastrointestinal malignancies, i.e., adenocarcinoma and squamous cell carcinoma as well as gastrointestinal stromal and other rare tumors of the esophagus and stomach. While, historically, surgical resection has been the sole treatment for these tumors, multimodal therapies have meanwhile proven their efficacy. At present, pre- and postoperative chemotherapy and radiotherapy, targeted drug therapy, and stage-specific surgical approaches are all indispensable cornerstones of an individualized treatment for upper gastrointestinal malignancies. With such multimodal treatment, better outcomes comprising improved quality of life and prolonged survival have been achieved for patients. However, for many tumor entities and stages, the ideal combination and sequence of treatments is still being evaluated in clinical trials. Moreover, the value of novel approaches such as immunotherapy or robotic surgery remains a matter of research. In this Special Issue of Cancers, up-to-date original research, short communications, and comprehensive review articles on all modalities playing a role in the treatment of upper gastrointestinal malignancies have been published.
Public health & preventive medicine --- gastric cancer --- gastrectomy --- complications --- outcome --- survival --- lymph node ratio --- neoadjuvant chemotherapy --- conversion surgery --- cancer dormancy --- nuclear receptor NR2F1 --- clinical pathways --- gastric surgery --- oncological gastrectomy --- quality of care --- outcomes --- standardization --- adjuvant therapy --- gastrointestinal tract --- genetic diagnosis --- radiosensitivity --- mortality --- failure to rescue --- immunotherapy --- genetics --- esophageal cancer --- multidisciplinary --- gastric/gastroesophageal cancer --- perioperative chemotherapy --- overall survival --- relapse-free survival --- skeletal muscle index --- esophagectomy --- nutritional status --- sarcopenia --- esophageal anastomosis --- minimally invasive surgery --- induction chemotherapy --- chemo-radiotherapy --- neoadjuvant treatment --- esophageal squamous cell carcinoma --- multimodal treatment --- neoadjuvant chemoradiotherapy --- definitive chemoradiotherapy --- Lauren histotype --- gastrointestinal stromal tumor --- neuroendocrine tumor --- MALT lymphoma --- mucosal resection --- submucosal dissection --- GIST --- stomach --- neoadjuvant therapy --- imatinib --- organ preservation --- squamous cell esophageal cancer --- gastro-esophageal reflux disease --- Barrett's esophagus --- early adenocarcinoma of esophagus --- endoscopic submucosal dissection --- endoscopic mucosal resection
Listing 1 - 10 of 12 | << page >> |
Sort by
|